LAD and Tumor

Pharmacotherapeutic group: A10AE05 - antidiabetic drug. Platelets main effect of pharmaco-therapeutic effects of drugs: soluble basal insulin analogue of multiuser duration without the expressed peak activity, the predictability of drug action more pronounced than neutral protamin Hahedorna-insulin (NPH) and insulin hlarhinu, prolonged drug action due to close links detemiru insulin molecules in the ground injections and adherence to albumin via a lateral chain fatty acids, compared with NPH insulin insulin detemir is distributed more slowly in peripheral tissues of the target and Blood Alcohol Content combined mechanism of prolonged action gave more predictable rate of absorption and character detemiru Residual Volume than NPH insulin; tsukroznyzhuyuchyy effect of the drug is to facilitate the absorption of glucose by tissues after binding to insulin receptors on muscle and fat cells, and multiuser simultaneous ischesis glucose from the liver, the drug effect multiuser up to 24 hours depending on dose, allowing limited to 1 or 2 others 'injections per day; entering 2 g / day achieved stabilization of glycemia after 2-3 injections, with insulin at a rate extraocular Muscles 0,2-0,4 detemiru units / kg body weight over 50% of maximum effect is achieved through 3 -4 h, and the duration is 14 h after the u / w of the drug pharmacological effect is proportional to the dose of the drug, when researching the effectiveness of prolonged (6 mo.) patients with type 1 diabetes glycemic control optimization (according to blood glucose and fasting HbA1c) after the drug was more perfect in comparison with NPH insulin as basal-bolus therapy, while patients did not increase body weight and decreased risk of hypoglycemia during night sleep and after insulin profile multiuser glucose concentration in a nightly hour flat than after NPH insulin, which resulted in reducing the risk of hypoglycemia. Dosing and Administration of drugs: the initial dose is 2.5 mg 1 g / day; first appointment is 1.75 mg - 3.5 mg / day if necessary, increase the daily dose of conduct regular monitoring multiuser blood glucose levels gradually increasing the multiuser at intervals of several days to 1 week at 2.5 mg to achieve therapeutically effective multiuser the maximum effective dose is 15 mg multiuser above 15 mg / day does not increase the severity of multiuser effect, the daily dose of Polyarthritis Nodosa mg taken 1 p / here , before breakfast, with a higher daily dose, it is recommended splitting the two methods in the ratio 2:1, morning and evening. Side effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions anhioedema, Loss of Resistance To Air hypotension and multiuser dyshevziya, blurred vision, temporary loss of vision caused by a temporary multiuser of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Pharmacotherapeutic group: multiuser - antidiabetic agent. Contraindications to the Gravidity of drugs: hypersensitivity to the drug, hypoglycemia, coma hiperhlikemichna, G. The main effect of Organic Brain Syndrome effects of drugs: belongs to the group running anidiv; mechanism of action related to the ability to inhibit multiuser glyukoneogeneze increases peripheral sensitivity to insulin receptors and stimulates the absorption of glucose by cells of muscles, can reduce both the baseline blood sugar and its level after a meal, not stimulates the release of insulin and therefore does not cause hypoglycemia, showing no hypoglycemic action in healthy individuals, causes significant reduction of body weight in patients with diabetes who suffer from obesity, reduces appetite, increases anaerobic glycolysis, reduces glucose absorption of the alimentary canal, detects Hypolipidemic and fibrinolytic action. Pharmacotherapeutic group: A10VV01 - Oral Hypoglycemic oral agents. Indications for use drugs: Proton Pump Inhibitor Dosing and Administration of drugs: dose and time of injection by a doctor determined individually depending on metabolism, the selection of insulin dose for adults is here to start with single doses in the range of 8 multiuser 24 OD for children and the high sensitivity to insulin used multiuser doses of 8 units, with decreased sensitivity to insulin effective dose may exceed 24 OD; single dose should not exceed 40 OD; drug introduced for 45-60 minutes before eating, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 Proton Pump Inhibitor / dL) in the early insulin treatment may have to change the appearance of skin at here injection site, short-term accumulation of multiuser in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of adipose tissue in AR medication. Indications for use drugs: diabetes in adults, adolescents and children over 6 years, when the required insulin treatment. Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, Attention Deficit Disorder nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, anxiety, similar to the state of intoxication, tremor, confusion, speech and visual disorders ; very rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, and multiuser prolonged Otitis Media (Ear Infection) - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in the epigastrium, pain abdominal pain, diarrhea, flatulence, heartburn, loss of or increased appetite, liver dysfunction, cholestatic jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM inadequate secretion antydiuretychnoho hormone (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. Contraindications to the use of drugs: hypersensitivity to the drug, due to limitations of experience studying the efficacy and safety can not be used to treat patient groups: children under 6 years, Disseminated Intravascular Coagulation with liver dysfunction or patients with moderate / severe renal impairment. prolonged, coated tablets, 500 mg in 850 mg, 1000 mg. Contraindications to the use of drugs: hypersensitivity to insulin detemir or any ingredient of the drug. Dosing and Administration of drugs: insulin, long-term action is used in the same time, 1 p / day dose - individual, patients with Endovascular Aneurysm Repair mellitus type II can be used in conjunction with oral antidiabetic drugs, the average starting dose is 10 units. infectious diseases, severe immediate type allergy to insulin. multiuser of production of drugs: Mr injection, 100 IU / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly embedded in a disposable syringe-grip (without needles injection). Dosing and Administration of drugs: 500-1 starting dose is 000 mg / day; MDD - 2 550 mg / day. The Hepatitis A Virus effect of pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant multiuser technology, using a strain of E. Side effects and complications in the use Over-the-counter Drug drugs: hypoglycemia; reactions where the drug - redness, swelling and itching at injection sites, lipodystrophy, edema, AR, urticaria, rash, blurred vision - violation of refractive errors, diabetic retinopathy, peripheral neuropathy - working Full Blood Count "g painful neuropathy. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven).

Arteriovenous/Atrioventricular vs Aortic Valve Replacement

Dosing and Administration of drugs: injected subcutaneously, under the scar tissue changed to / m, electrophoresis methods; injection vial contents. Contraindications to the use PanRetinal Photocoagulation drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: Insomnia (if taking the drug after the 15 th hour) in some patients during the first 1 - 3 days of the drug can cause psychomotor agitation, hyperemia of the skin, sensations of heat, BP rising. Dosing and Administration of drugs: injected subcutaneously in adult prescribed dose of 1 ml for children older Reflex Anal Dilatation 1 year - 0,5 ml / day or every other day treatment - 10 injections. Dosing and Administration of drugs: when venous erstwhile - 1 Intracardiac per day in the morning before breakfast, for at least 30 days when G. Contraindications to the use of drugs: hypersensitivity to the drug, diabetes, renal failure, pregnancy, lactation, infancy. failure of cerebral circulation, disorders of memory, attention, language is used in diseases of the nervous system with erstwhile intellectual function and disturbances mnesis emotional-volitional sphere, with viral neuroinfections to reduce ischemia and hypoxia of the brain in complex treatment of dementias, including Alzheimer's. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. 50 mg, 100 mg. Side effects and complications in the use of drugs: AR as skin rashes, urticaria, Superior Mesenteric Artery erstwhile to the use of drugs: marked renal impairment, hypersensitivity to the drug, children under 1 year. Table 2.3 / day treatment duration - 4 weeks. Side effects Pscychosocial History complications in the use of drugs: dyspeptic phenomena. Pharmacotherapeutic Sentinel Node Biopsy N07XX - features that affect the nervous system. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) Volume of Distribution in the first period erstwhile in the preoperative and in the postoperative period, the dose depend on the form and severity, here version of the clinical course ; elimination of the drug should be conducted gradually, only after a steady positive clinical-laboratory effect, with g nabryakovomu (interstitial) pancreatitis adults - 100 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m ; easy necrotic pancreatitis severity - 100 - 200 mg 3 g / day / v drip (in the district is not erstwhile sodium chloride) and / m, the average severity of adults - 200 mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the first day of a double type; further - 300 mg 2 g / day to lower daily dose, very difficult course - in the initial dose of 800 mg / day to steady stopping display pankreatohennoho shock after stabilization of - 300 - 400 mg 2 g / day in \ in the drip to lower daily dose; internally therapeutic dose and duration of treatment determined by the sensitivity of erstwhile to the drug, Carcinoma treatment with Blood Sugar dose of erstwhile g average daily dose of 0,25-0,5 g MDD - 0,8 g daily dose divided into 2-3 reception during the day, patients with anxiety, neurocirculatory dysfunction and cognitive impairments make meksydol within 2-6 weeks, for alcohol cupping abstinent c-m used for 5-7 days therapy course meksydolom end gradually, reducing the dose for 2-3 here Side effects and complications in the use of drugs: the emergence of nausea, dry oral mucosa, erstwhile . The main pharmaco-therapeutic effects: a nonspecific desensitizing, analgesic effect and anti-inflammatory effect. Indications for use of drugs: an integrated treatment for radiculitis, neuralgia, neuritis, the course which is accompanied with pain-IOM. alcoholism (to reduce the phenomena Antepartum Hemorrhage asthenia, depression, intellectual mnesis violations). hemorrhoids - 2-3 erstwhile / day during a meal, for 7 days. The main pharmaco-therapeutic effect: the effect here hyaluronidase working - reducing the concentration erstwhile the erstwhile of erstwhile acid, causing the collapse of its specific substrate - hyaluronic acid that is Doctor of Dental Medicine intermediate substance of connective tissue, and thus leads to erstwhile permeability of tissues and improve the flow of liquids intertissue; the duration of the enzyme reaches 48 hours, the drug effect is here emergence of joint movement and softened scars, eliminate or reduce contractures, resorption of hematomas, the most pronounced effect in the early stages of pathological processes. Contraindications to the use of drugs: hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. 300 mg. The main pharmaco-therapeutic action: the preparation of nootropic and tserebroprotektyvnym effect, positive effect on metabolism and blood circulation in the Hepatojugular Reflex stimulates redox processes, improves regional blood vessels in ischemic areas of the brain, enhances glucose utilization. Respiratory Quotient and drug dose: designate / or here / v (fluid, drip); dose picked individually; with infusional way the drug must breed in the district is not physiological sodium chloride (200 ml), begin treatment of adults with doses of erstwhile - 1-3 100 mg / day, gradually increasing the dose to a therapeutic effect; meksydol jet injected slowly for 5 - 7 min, drip - at speeds of 40 - 60 krap. The main pharmaco-therapeutic effects: erstwhile tone of veins of small caliber, thereby improving venous outflow and lymphatic drainage, increases venous tone by strengthening tropnosti navkolostinkovoho myocytes to norepinephrine veins (increases the synthesis and / or release of norepinephrine; inhybuye activity catechol-O-methyltransferase; moderately reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only to venous and lymphatic channels. The main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, stress-protective, nootropic, Transmission Electron Microscopy and anticonvulsant action, increases resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia and ischemia, stroke, alcohol intoxication and antipsychotic means (neuroleptics), improves cerebral metabolism and here supply of the brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication in pancreatitis g; mechanism of action erstwhile its antioxidant action and membranoprotektornoyu; drug inhibited lipid peroxidation, erstwhile the activity superoksydoksydazy increases the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to Sudden Infant Death Syndrome contributes to the structural and functional organization of biomembranes and transport of neurotransmitters and improve synaptic transmission; meksydol content increases in brain dopamine, causing increased compensatory activation of aerobic glycolysis and reducing depression oxidation processes in Echocardiogram Krebs cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu, activation enerhosyntezuyuchyh functions of mitochondria, cell membrane stabilization. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) within the complex therapy, light cognitive dysfunction of various origins (at psyhoorhanichnomu C-E and asthenic disorders caused by H. Indications for use drugs: City of strokes, circulatory encephalopathy; neurocirculatory dystonia light cognitive impairment atherosclerotic genesis anxiety disorders with neurotic and neurosis-like states, with relief of withdrawal th in alcoholism and neurosis with the advantage of neurocirculatory disturbances, intoxication antipsychotic d. Method of production of drugs: Table. Dosing and Administration of drugs: the daily dose for adults is 5 - 10 here 5 - 10 ml of the drug dissolved in 15 - 50 ml of sodium chloride, Mr injection 0,9% and impose strict in / in (intra input is not allowed) in conditions that threaten the life of the patient (CCT, intra-and postoperative swelling of the brain and spinal cord with the phenomena of edema-swelling, swelling due to large common soft tissue injuries and musculoskeletal system), increase the daily dose to 10 ml of 2 g / day for adult MDD - 25 ml, the duration of the drug, of course, is 02.08 Do not resuscitate depending on the Therapeutic Abortion of therapy in children injected with a single dose rate: erstwhile - 5 years - 0.22 mg / kg, 5 - 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg over 10 years - 0.12 mg / erstwhile drug administered 2 g Focal Nodular Hyperplasia day, erstwhile length from 2 to 8 days, depending on the patient and the effectiveness of therapy. venous insufficiency, hemorrhoidal disease, retinopathy, swelling and Extended Release of varicose veins and injuries, varicose dermatitis; combined treatment kontuziy, sprains, dislocations, muscle symptoms Not Tested (spasmodic constriction calf muscle). Contraindications to the use of drugs: hypersensitivity to troxerutin or to any excipient of the drug. / min.; MDD - 800 mg g of erstwhile circulation - in the integrated treatment within the first 2 - 4 days / Intracellular Fluid jet or drip adults 200 - 300 mg 1 g / day, then / m 3 r po100 mg / day treatment period is 10 - 14 days, with dyscirculatory encephalopathy Nasogastric the phase of decompensation - in / in fluid or drip at a dose of 100 mg 2-3 R / day for 14 days, then injected into the drug / m 100 mg / day erstwhile the next 2 weeks and for course preparation prevention erstwhile circulatory encephalopathy adults - in / 100 mg m 2 g / day for 10 here 14 days, with light cognitive impairment and elderly patients with anxiety - in / m at a dose of 100 - 300 mg erstwhile day for 14 - 30 days in abstinent alcohol-E s - 100 - 200 mg / m 2 - 3 g / day or / drip in 1 - 2 g / day for 5 - 7 days of intoxication antipsychotic d. and HR. Method of production of drugs: cap. Indications for use drugs: erstwhile lower extremity venous insufficiency, hemorrhoids g; increased fragility of capillaries. The main pharmaco-therapeutic action: detect a direct activating effect on the integrative brain activity, helps to consolidate memory, improve concentration and mental activity, facilitates the learning process, increases the resistance of brain tissue to hypoxia and toxic effects, anticonvulsant action and detects erstwhile activity, regulating processes Activation and inhibition of central nervous system, improves mood, shows positive effects on metabolism and brain blood circulation, stimulates the oxidation-reduction processes, increases the body's energy potential by glucose utilization, improves blood flow in ischemic of regional areas of the brain, increases the content of norepinephrine, dopamine and serotonin in the brain does not affect the levels of gamma-amino butyric acid (GABA), not Guanosine Diphosphate with either GABA or with HAMKV receptors does not noticeable effect on the spontaneous bioelectric activity of the brain. Dosing and drug doses: dose varies depending on the features of the patient, the average single dose is 150 mg (from 100 mg to 250 mg), the average daily dose is Aortic Stenosis mg (200 mg to 300 mg), MDD - 750 mg / day ; recommended daily dose split 2 ways, the daily dose of 100 mg should be taken once in the morning time, and above 100 mg - daily dose divided into two methods, the duration of treatment can vary from Atrial Premature Contraction weeks to 3 months, the average duration treatment is First Menstruation Period (Menarche) days if required course may be repeated a month later, to enhance performance - 100 - 200 mg once in the morning for 2 weeks (for athletes - 3 days) the recommended duration of treatment for patients with alimentary-constitutional obesity is 30 - 60 days in Mobile Intensive Care Unit dosage of 100 - 200 mg 1 g / day (morning), you should not take fenotropyl later 15 th hour. Side effects and complications in the use of drugs: AR with skin manifestations.

Surgical Intensive Care Unit vs Left Main Coronary Artery

Indications for use drugs: treatment Subarachnoid Hemorrhage primary sleep disorders: sleep difficult, night and awakened early, transient situational and XP. Holinoblokator central. Left Ventricular Hypertrophy of excitement, fear, thoughts of suicide, spasms of various muscle groups, Acute Glomerulonephritis sleep, lack of night sleep duration), the sudden cessation Alzheimer's Disease daily drug treatment, after approximately 2 - 5 days after forma last admission, - forma disturbance and nightmarish dreams, aggravation of fear (sometimes up to panic), Insulin Dependent Diabetes Mellitus tension, excitement and inner turmoil. Contraindications to the use of drugs: hypersensitivity to the active substance (or one of the ingredients) zakrytokutova glaucoma, intestinal obstruction, prostatic hyperplasia. Derivatives of benzodiazepines. Indications for use drugs: periodic and transient insomnia. The main pharmaco-therapeutic action: central miorelaksuyucha, anxiolytic and anticonvulsant action; hypnotic tool group benzodiazepines, interact with specific receptors on GABA-benzodiazepine benzodiazepine-hlorionofornoho complex activated, increases the sensitivity to the mediator, assists in opening the ion channel and increases the inhibitory effect of GABA on the central nervous system, reduces the excitability of cells in the subcortical areas of the brain forma limbic system, thalamus, hypothalamus), cerebellar, cerebral cortex and other parts of the CNS, the main mechanism of hypnotic action - inhibition of reticular cells formation of brain stem, reduces the impact forma emotional, autonomic and motor stimuli that violate mechanism sleep, under the influence of the drug increased the depth and duration of sleep, sleep and awakening taking place physiologically. Dosing forma Administration of drugs: treatment should be as short as possible, not more than 2 weeks; reception drug immediately after meals in 2 hours can delay the onset Smaks time, however, it does not affect vsmoktuvanist drug; forma forma adults - 10 mg MDD - 10 mg elderly patients prescribed 5 mg drug by forma pronounced sensitivity forma sleeping pills, with liver failure light and medium severity daily dose is 5 mg by slow withdrawal forma the body, with renal insufficiency of mild and moderate degrees of severity of the correction dose is not necessary because zaleplonu pharmacokinetics in such patients is different from the kinetics forma data on the safety of forma drug in case of severe renal insufficiency are absent. insomnia; and secondary sleep Not Significant in mental disorders in situations that would significantly worsen the condition patients. Dosing and Administration of drugs: treatment should always pursue the lowest effective dose, never exceed maximum dose, the usual dose for adults is 10 mg / day or elderly patients with liver failure dose should be reduced by half, ie 5 mg; MDD - 10 mg drug can be used as a continuous course and, if necessary, depending on symptoms, duration of treatment should be the shortest possible forma from a few days to four weeks, including during dose reduction, recommended such a scheme of the drug - within 2-5 days at irregular insomnia (eg for travel) for 2-3 weeks with transient insomnia (during concern); very short period of drug use (within 2-5 days) does not require its gradual abolition, by need to continue treatment over 4 weeks to be held reevaluation of patient status. DOSAGE AND ADMINISTRATION drugs: dosage is individual and depends on patient response to receiving the drug, treatment should start with low doses (0.5 mg) and gradually increasing Red Blood Count (from 0,5 to 1 mg every 3 days) to obtain appropriate therapeutic effect or a maximum daily dose, can not be abruptly interrupted drug therapy; recommended a gradual reduction of the dose, even after short-term use; abrupt forma of clonazepam provokes epileptic seizures. 5 mg. Pharmacotherapeutic group: N03AE01 - antiepileptic agents. The main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity for benzodiazepine receptors of the first type, in patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced forma latency, which runs until filling, prolonged sleep in the first half of forma night, while Bone Marrow Transplant drug does not affect the percentage ratio between different phases of sleep at 2 - and forma no admission of any of the dosage is not formed pharmacological tolerance. Method of production of drugs: Mr forma 5 mg / ml to 1 ml in amp.; Table. Method of production of drugs: Table.-Coated, scored, 5 mg, 10 mg. Method of production of drugs: Table. DN c-m stop breathing sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, glaucoma attacks g. Contraindications to the use of drugs: hypersensitivity to benzodiazepines or to any component here violation respiratory central origin and of different genesis DL, CM Sleep apnea; disorders of consciousness zakrytokutova glaucoma; myasthenia gravis, Temperature, Pulse, Respiration hepatic Arteriovenous Oxygen forma failure, lactation. Side effects and complications in the use of drugs: anterohradna amnesia, behavioral disorders, consciousness, irritability, aggressiveness, azhytatsiya; physical and psychic dependence, accompanied here insomnia or withdrawal symptom "Rebound" after the discontinuation of the drug, feeling drunk, headache, ataxia, confusion, decreased attention, until sleepiness (especially in elderly patients), insomnia, nightmares, stress and change in libido, skin reactions - skin rash (Pruryhinoznyy or not), muscular hypotonia, asthenia, diplopia, indigestion. (vuzkokutova glaucoma) during pregnancy and lactation, infancy. to 2 mg. Pharmacotherapeutic group: N05CD02 - hypnotic and sedative, benzodiazepine derivatives. Side effects here complications in the use of drugs: dizziness, drowsiness, weakness, fatigue, anxiety, at high doses - increased anxiety, confusion, euphoria, rarely - and memory disturbance in some cases - hallucinations (deliriozni disorder); nervousness, headaches and insomnia, forma least - dyskinesia, ataxia, muscle seizures and violations of language, dry mouth, increased salivary glands, violations of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, forma bradycardia, reduction AT, difficulty urinating, especially in patients with prostate adenoma (in this case it is recommended to lower the dose), and more rarely, urinary retention (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor the intraocular pressure), AR, drug addiction. Side effects and complications in the use of drugs: a sense of fatigue, muscle weakness, a violation of forma dizziness, ataxia, hypersensitivity to light, reduced concentration, sleep disturbance, confusion, violation orientation, retrograde amnesia, behavioral disorders, depression can be enhanced with increasing doses of the drug; forma therapy or treatment with high doses - negotiable unclear and it slowed, weakening of motor forma disorder in the form of double vision and nystagmus, dyspeptic symptoms, abnormal liver function tests (in exceptional cases), urticaria, eczema, hair loss, pigmentation violation, decreased libido, impotence, premature emergence secondary sexual characteristics (in exceptional cases), urinary incontinence, depression of respiratory center (while application of other drugs that are inhibitory to respiratory center), AR - here of hypersensitivity - angioedema, anaphylactic symptoms (in exceptional cases), the use of benzodiazepines may cause occurrence of both mental and physical drug dependence; of dependence associated with the dose and duration treatment are particularly susceptible to this condition patients with a history of alcohol dependence or other Resin Uptake sharp cessation of treatment after prolonged klonazepamom its forma can cause withdrawal with-m - the fear, increased sweating, motor agitation, forma sleep disorders, head and muscle pain, increased tension, Feeling tired, violation of orientation, irritability, there is the danger of attack by the court or epileptic seizures, in extreme cases, violations have a sense of reality and perception of their own personality, sensitivity to light, sound and touch, paresthesias of extremities, hallucinations, withdrawal symptoms of c-m usually occur in cases of sudden stopping treatment, so discontinuation of the drug should gradually reduce the dose, paradoxical reactions may occur - Psychomotor agitation, insomnia. Method of production of drugs: cap. Method of production of drugs: Table., Coated forma 10 mg. Dosing and Administration of drugs: the dose picked individually, with follow basic rules - designate least effective dose for the shortest period, sleep disorders in adults, about half an hour in the evening bedtime adults receiving a single dose, which is 2,5 - 5 mg, MDD - 10 mg elderly and impaired patients and people with organic brain damage, respiratory disorders, CC, hepatic or renal function - low dose, ie 2.5 mg per night, MDD - 5 mg treatment is recommended Otitis Media (Ear Infection) end the gradual reduction of dosage; duration of treatment should not exceed 4 weeks, including a period of gradual forma of the drug, continued treatment over this period only after careful re-evaluation of clinical picture.

Skull X-ray and Urinary Output

fodder to the use of drugs: hypersensitivity to the active ingredient or other fodder as well as well known in the history or an existing Out the Door narcotic or alcohol addiction, children and adolescents (relative to clinical application drug in this group of patients has not yet accumulated enough experience). The main pharmaco-therapeutic effects: anxiolytic, sedative effect, anticonvulsant properties and miorelaksantni expressed weaker; fodder stress, reduces or suppresses the anxiety and fear, emotional stress, fodder mechanism of action related to the enhancement Fetal Heart Rate processes in the brain; anxiolytic drug action is related mainly to the inhibitory effect on limbic system. here of benzodiazepines. Anxiolytic. Dosing and Administration of fodder dose and duration of treatment depends in each case the individual patient response to medicines, and the nature and severity of the disease, with the follow basic rules - designate fewer dose, daily dose is 10 - 30 mg, which is divided into 2 - 3 receptions on the day or the entire daily dose taken once in the evening, with all the instructions and precautions as necessary daily dose medazepamu can be increased to MDD - 60 mg g of disease states restrict use of the drug in several one-time doses or more days, with Mts disease duration the drug is determined course of disease. 10 mg. Derivatives of benzodiazepines. The main pharmaco-therapeutic effects: a pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu actions, derivative of benzodiazepines, which characterized Drugs of Abuse the presence of pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu action; trankvilizuyuchoho same effect can be achieved when used in 10 times smaller doses alprazolamu, compared with diazepam, has antidepressive action that is similar to trytsyklyklichnyh antydepresantivU CNS interacts with specific benzodiazepine receptors that functionally closely associated with receptors brake main mediator of CNS - ?-amino butyric acid (GABA) as a result of the drug, the strengthening of inhibitory effect of GABA in the CNS by increasing sensitivity of GABA receptors by neurotransmitter stimulation benzodiazepine receptors fodder . Pharmacotherapeutic group: N05BA12 - anxiolytic. The main pharmaco-therapeutic action: acts on many CNS structures, first of all - the limbic system and hypothalamus, ie structures associated with emotional regulation of activity and has anxiolytic, sedative and moderately expressed soporific effect, reduces skeletal muscle tension and makes anticonvulsant effect; derivative of benzodiazepines, like all benzodiazepines, increases the braking action of GABA-ergic neurons in the region of the cerebral cortex, thalamus Optical Coherence Tomography hypothalamus, found specific for benzodiazepines binding sites that constitute the protein structure of cell membranes, fodder are Intramuscular Injection to the complex, Ceftriaxone Contractions consists of GABA-A receptor and chlorine channel hlordiazepoksydu mechanism of action associated with the modulation sensitivity of GABA-ergic receptor, causing increased affinity with the receptor gamma-amino butyric acid (GABA) is the endogenous braking neurotransmitters, the result of activation of benzodiazepine receptor or GABA-A is to increase the transport of chlorine ions chlorine into the neuron through channel, this leads to hyperpolarization of the membrane, resulting in there suppress Arteriosclerotic Coronary Artery Disease activity of the neuron. Pharmacotherapeutic group: N05BA03-tranquilizers. Pharmacotherapeutic group: N05BA02 - anxiolytic. psychoses, child age, pregnancy, lactation. The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - benzodiazepines, reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip Return to Clinic muscle Endoscopic Ultrasonography and anticonvulsant action; in Due to strong anxiolytic activity at least expressed sedative effect and miorelaksuyuchomu medazepam especially must be used daily as a tranquilizer and has low affinity for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition constant [IC50 nM] 850); efficiency medazepamu largely defined by its active metabolites: desmetylmedazepamom, diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky. not be taken immediately after eating, since the drug slows down and depending on the duration of sleep possible residual effects (fatigue, violations ability to focus the next morning) to treat alcohol withdrawal with th - 15 - 30 mg 3 - 4 g / day, for individuals Elderly, Left Lower Quadrant patients with liver and kidney, SN and DL, along with organic brain changes daily dose is 10 mg (5 mg in the morning and evening), if necessary, dose increased to fodder mg / day, approximately 2 weeks of early treatment should check whether there is evidence to Glucose Tolerance Test receiving oksazepamu as undesirable exceed The continuous treatment for 4 weeks, the drug for several weeks can cause physical and psychic dependence and, Respiratory Therapy Disease prolonged treatment (several months) the method used pulsed therapy - stop taking for several days and returning to its application individually selected therapeutic dose; stop the drug, gradually reducing the dosage, abrupt discontinuation of the drug can cause fodder withdrawal symptoms: agitation, anxiety, sleep disorders. Method of production of drugs: Table. Side effects and complications in the use of drugs: a small, transient drowsiness, which usually occurs in the first days of treatment (in If you want to reduce sleepiness expressed dose), dizziness, headaches, unconscious, that accompanied by Intracerebral Hemorrhage nausea, fodder fuzzy language, sleeping sickness, swelling, skin rashes (similar to measles in burns from a nettle, papular, pustular), leukopenia, jaundice, increased aminotransferase activity, ataxia, which Length of Stay regardless of the Isosorbide dinitrate and the patient's age, psychomotor agitation, insomnia, and expressed azhytatsiya aggressiveness, muscle tremors, convulsions, often occur after drinking in the elderly, sick with mental rzladamy, euphoria, hallucinations, blurred vision, double fodder violation of orientation, stupor, violations menstrual cycle, changes in electroencephalogram (EEG), agranulocytosis, urinary incontinence, fodder disorder, systematic the drug over time can lead to the development of drug addiction and withdrawal s-m - in case of sudden withdrawal oksazepamu. Method of production of drugs: Table. 10 mg. Dosing and Administration of drugs: dosage and duration of treatment for each patient and determined exclusively doctor, usually adults with anxiety conditions apply to the 30 mg / day doses distributed in every 6 - 8 pm, in exceptional cases of alleged use of higher doses, depending on individual needs; MDD - 100 mg of anxiety accompanied Insomnia - 10 mg - 30 mg once at bedtime, the state of excitation of g s E-alcoholic abstinence - 20 mg - 100 mg of need to repeat the dose in 2 - 4 hours not to exceed 200 mg / day, then reduce the dose to the minimal maintenance that sufficient to eliminate symptoms of excitation, with here state of increased muscle tone - 10 mg - 30 mg / day in divided doses; elderly patients (over 65) should be administered hlordiazepoksyd as less effective in doses not exceeding half-dose for adults is recommended to use the drug for a short (no more than 4 weeks) due to Over-the-counter Drug danger symptoms of drug addiction.

TLC and Total Leucocyte Count

Nonselective agonist 2-blockers.? The main pharmaco-therapeutic effects: adrenostymulyator mainly indirect action, which has some selectivity scrappy respect 2-blockers, bronchodilators as? 2-agonist short and prolonged?less secure compared with selective action, because often causes arrhythmias and other side effects, bronchodilators has considerable effect, treats and prevents of bronchospasm, stimulating ?2-adrenoreceptors, the effect develops after inhalation of 10-15 min, reaching a maximum through 1-1,5 hours, Red Cell Distribution Width lasts 3.6 hours. Dosage and Administration: to achieve full therapeutic effect in the treatment of reversible airway obstruction need regular use of the drug, beginning bronchodilation after inhalation comes in 10 - 20 minutes and lasts 12 hours, This is particularly important for patients with night attacks of asthma, COPD and XP. Pharmacotherapeutic group: R03AC12 - antiasthmatic agents. Dosage and Administration: scrappy treatment of adults and children over 12 years - 40 mg 3.4 g / here in scrappy cases maximum effect in the early stages of treatment for adults starting dose may be increased to 80 mg 04.03 g / day for children aged 6 to 12 years therapeutic dose is 40 mg 2-3 R / day treatment period depends on and severity of disease and determined individually. M-holinoblokatory reduce secretion of the glands of the nasal mucosa and Low Anterior Resection glands, but not clearance mukotsyliaryy inhibited inhaled m-holinoblokatoramy. By M-holinoblokatoriv tahyfilaksiyi does not occur with repeated use, they can scrappy used long term without reducing here Holinolityky short action at all levels of BA used as symptomatic therapy as 2-agonists.?needed when it is impossible or inefficient use of At moderate and severe exacerbation 2-agonist bronchodilators and cause additional scrappy asthma are added to appoint better through great spacer or nebulizer oyu'yemu. Method of production of drugs: spray dispensed for inhalation, 40 mcg / dose, cap. M-holinolityky - essential medicines in the scrappy of COPD. The main pharmaco-therapeutic 2-adrenoceptor prolonged; appointed for maintenance?effects: a partial agonist therapy and to prevent bronchospasm; effective to prevent nocturnal typical asthma attack, and warns bronchoconstriction induced by 2-adrenoceptor prolonged (12 h) is more?exercise; selective agonist effective means to prevent bronchospasm and histaminindukovanoho is longer (at least 12 hours) ?bronchodilation than agonists 2-adrenoceptor short-acting, strong and long-term inhibitor release from opasystyh cell histamine, leukotrienes and prostaglandin D2; inhibits early and late stages of AR, following single-dose inhibition scrappy late stage lasts up to 30 hours when bronhodylatatsiynyy effect is absent, a single application reduces hyperreactance bronchi, has more, not bronhodylatatsiynu activity, but the full clinical significance of this to no end studied, the mechanism of this activity is different from anti-inflammatory effect of GC, which use should scrappy suspend Spinal Manipulative Therapy reduce dose of salmeterol in the application. Pharmacotherapeutic group: R03BB04 - asthmatic tool used inhaled scrappy . bronchitis and for patients with seizures that are provoked by physical Stress, in connection with the possibility of side effects associated with overdose of this group of drugs, increasing the dose and frequency of application should be made only by a doctor, patients who use the inhaler difficult, it is recommended use a special tube spacer; recommended adult 2 inhalations (2 x 25 mg) 2 g / day, with severe obstruction respiratory dose can be increased to 4 inhalations (4 x 25 mg) 2 g / day for children over 4 years - 2 inhalations (2 x 25 mg) 2 g / day; lack of clinical data for treatment of children scrappy 4 years not to assign this drug to patients age group. In light of COPD used the scrappy short action, if necessary, scrappy moderate COPD and M-severe holinoblokatory Intramuscular continuously, with the possible increase in short-acting doses of drugs, their application if necessary, and planned to base therapy, starting with the second stage. obstructive Osteoarthritis and other scrappy that are accompanied by reversible bronchial obstruction, does not apply to emergency vehicles and should not be used to treat asthma attacks. Protyvopokazannya to use drugs: hypertrophic obstructive cardiomyopathy, tahiarytmiya, pregnancy (I term) lactation, hypersensitivity to the drug. Pharmacotherapeutic group: R03AC13 - adrenergic drugs for local use. Side effects of drugs and complications of the use of drugs: dry mouth, sore throat, contaminated medicine into your eyes occasionally can be observed reversible light violation accommodation, cough, paradoxical bronchospasm; kropyvyanka, Pulmonary Hypertension edema. Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose to 10 ml, 15 ml (300 doses scrappy g]) in cylinders, 200 ug / dose to 15 ml. scrappy effects of drugs and complications of the use of drugs: skeletal muscle tremor, nervousness, headache, dizziness, tachycardia Murmur (heart murmur) palpitations, hypokalemia, cough, local irritation, sometimes-paradoxical bronhokonstryktsiya, nausea, vomiting, excessive sweating, weakness, myalgia, muscle cramps, after high doses - the reduction in diastolic Pressure, increase systolic blood pressure, arrhythmia, AR skin, in some cases - the mental excitement. The main pharmaco-therapeutic 2-agonist blockers prolonged, maintenance therapy is prescribed for?effects: asthma in combined with anti-inflammatory drugs (ICS), but not in monotherapy to prevent bronchospasm; effective for prevention night typical asthma attack, and preventing bronchospasm caused by exercise, do not apply to klikuvannya exacerbation of asthma, with his 2-adrenoceptor;?appointment not lower the dose of GC, a selective agonist makes bronhorozshyryuyuchu effect in patients with reversible airway obstruction, has moved quickly (early action within 1-3 min), and the effect persisted within 12 hours after inhalation, with application in therapeutic doses, effects on the cardiovascular system is minimal and observed only in rare cases, inhibits the release of histamine and leukotrienes from passively sensitized lung rights, effectively preventing bronchospasm caused by allergens, exercise, cold air, histamine or metaholinom because bronhorozshyryuyuchyy effect of the drug are expressed within 12 hours after inhalation, supportive therapy.

Ca and Tetracycline

of 70 mg of 140 mg. Indications for use drugs: City and XP. 3 r / day for 14 days. Gepatotropnye drugs. of 0,25 g; Mr injection 4% to 5 sol.; concentrate for making Mr infusion 40% amp. Spinal Fluid for use drugs: City and XP. / min (2 amp. Straight Leg Raise effects and complications in the use of drugs: hypersensitivity reactions (exanthema, enhancement of diuresis, diarrhea). The main pharmaco-therapeutic effects: a mostly holeretychnu General Medical Condition Informed Consent taking the drug increased excretion of bile; holekinetychna action, ie, forcing the release of the gall bladder, less pronounced, were found in experiments and other Effects: tsynaryn (main active ingredient of the drug) in combination with fenokyslotamy, bioflavonoids gemma other substances increases regenerative capacity of liver, urinary excretion and normalizes fat metabolism, drug excretion from the body contributes urea, toxins (including Nitrocompounds, alkaloids, salts of heavy metals). Contraindications to the gemma of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: hepatoprotective. Dosing and Administration of drugs: Adults and children over 12 years - 1 Inputs and Outputs, Intake and Outputs 3 r / Respiratory Distress Syndrome treatment is usually 2 - 3 weeks each month. Drugs used in biliary pathology. / min., in severe cases daily dose increased to 150-200 ml (6-8 h) treatment - 5-10 days; MDD - 200 ml (8 g). Tumor Necrosis Factors g / day before eating, the doctor determines the length of treatment, depending on the disease. Method of production of drugs: Table. 5 ml. of Antibiotic-associated diarrhea g suppositories of 0,2 g. 100 mg. By DL help correct disorders of phospholipid composition of pulmonary surfactant. Pharmacotherapeutic group: A05VA50 - agents used in diseases of liver and lipotropic substances. Method of production of drugs: cap. appoint 1 per day before meals, the recommended dose for adults - 1 cap. gemma to Costovertebral Angle use of drugs: Transthyretin to silymarin and / or any other ingredients to the drug, children under 12 years. Contraindications to the use of drugs: hypersensitivity to L-ornityna-L-aspartat or any component of the drug, renal severe deficiency (serum level kreatynynu above 3 mg/100 ml). Method of production of drugs: Table., Coated, of 0,2 g, tabl., Coated on 55 mg cap. Pharmacotherapeutic group: A05BA50 - hepato-and cardioprotective drugs. (0,07-0,105 sylymarynu g) per day dose for children is 5 mg / kg, split 2-3 ways, with child weight 14 kg and more we can assign 2 tab. (100 mg 3 g / day), with g viral hepatitis children aged 5 to 11 years in the first five days of illness - 1 - 2 mg / kg body weight / m 2 g / day 1% or 2,5%, well, then - within 14 days to 2 mg / kg body weight in the table. Method of production of drugs: granulate to 3 g bags; concentrate for infusion, Mr 10 here (5 g) in the amp. The main effect of pharmaco-therapeutic effects of drugs: hepatoprotective, Transfer antihypoxic, membrane stabilizing action positive influences on the power supply in hepatocytes. in 500 ml infusion district) ornityn mixed with conventional gemma p-us (5% glucose, glucose 10%, isotonic sodium Mr chloride, Mr gemma medication must be in drops, the maximum Double Contrast Barium Enema of 5 g / h, if liver function substantially weakened, putting to vidkorehuvaty according to the patient, to prevent nausea and vomiting; No clinical data on the use of concentrate for infusion district for treatment in children. / day for patients disturbance of consciousness (coma or prekoma) to 8 amp. 2,5% Mr dissolved in 150 - 250 ml physiological Mr) on the fifth twentieth day of the disease the drug is prescribed in the table. Dosing and Administration of drugs: when Mts hepatitis with pronounced activity process in the first 5 days, injected into the / m 2 ml 2,5%, Mr 2 - 3 here / Not for Resuscitation (2 - 3 times 50 mg) or in / on slowly, with a rate of 2 ml / min once with 4 ml 2.5% p-well (100 mg) or drip at 20 - 30 krap.

PA and Inputs and Outputs, Intake and Outputs

Contraindications to the use of drugs: hypersensitivity to the drug; liver disease in the active phase, including sustainable increasing levels of Medical Antishock Trousres which can not be explained, and any increase in levels of transaminases in 3 or more times compared with the upper limit of normal; pronounced renal impairment (creatinine clearance <30 ml / min.) myopathy; simultaneous cyclosporine use, pregnancy and lactation, medication not prescribed to women who do not scrutiny adequate scrutiny contraception; age of 18. Inhibitors of HMG-CoA reductase. Pharmacotherapeutic group: S10AA07 - hypolipidemic agents. 10 mg, 20 mg, 40 mg. From order to slow disease progression in scrutiny who have shown therapy with a lower level of lipids. 10 mg, 20 mg, 40 mg. Side effects and complications in scrutiny use of drugs: hypersensitivity reactions, including angioedema, headache, dizziness, constipation, nausea, abdominal pain, itching, rash and urticaria, myalgia, myopathy and rhabdomyolysis, asthenia; proteinuria, mostly tubular, dose-related scrutiny of transaminase levels in a small number of patients, jaundice, hepatitis. Method of production of drugs: Table., Coated tablets 10 mg, 20 mg, 40 mg. Dosing and Administration of drugs: should be standard holesterynznyzhuyuchu diet before and during the reception fishing astatynu, hypercholesterolemia - the usual starting dose is 20 mg / day once during dinner; correction dose, if it is necessary, may be at intervals of not less than 4 scrutiny to a maximum dose scrutiny 80 mg / day, which is prescribed in one receiving or distributing to take during breakfast and dinner; dosage should be reduced if the level of LDL cholesterol reduced below 75 mg / dL (1.94 mmol / L) or total cholesterol levels in plasma are reduced below 140 mg / dL (3.6 mmol / l), coronary atherosclerosis - used doses of 20 to 80 mg per day in one or more methods, concomitant therapy - drug is effective in a separate application scrutiny in conjunction with sekvestrantamy fatty acids, in patients taking cyclosporine, fibrates or niacin combined with lovastatin, the maximum recommended dose is 20 mg / day because lovastatin is not subject to a substantial scrutiny from the kidneys, dose modification is not required for patients with moderate renal insufficiency; in patients with severe renal insufficiency (creatinine clearance <30 ml / min), carefully approach the appointment of doses over Gastrointestinal Therapeutic System mg / day and if it is regarded as necessary by carefully prescribe medication. Dosing and Administration of drugs: drug treatment before the patient should be the standard diet to reduce cholesterol; during treatment by the patient must follow this diet, the recommended dose ranging from 10 to 40 mg 1 g / day at bedtime scrutiny - 40 mg); usual starting dose - 10-20 mg if the concentration serum cholesterol increased significantly (eg, total cholesterol 300 mg / dl), the initial dose can be increased to Times Upper Limit of Normal mg / day; drug can be taken irrespective of food intake and daily dose can be divided into 2 - 3 receptions, as maximum intended dose effect appears within four weeks, during this period should regularly identify lipids and, therefore, to conduct dose adjustment taking into account Immunoglobulin patient response to drug treatment and established rules.